Fundraising FoxTascatx
Boston, US · 1 known investors
Find your way into Tascatx
Sign up to see every warm intro you have to Tascatx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Tascatx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Tasca Therapeutics develops novel cancer therapies using mass spectrometry-based proteomics to identify cancer-causing proteins with auto-palmitoylation modifications, targeting previously unknown binding pockets for difficult-to-treat cancers. The company's lead program, CP-383, is in preclinical development with expected clinical trial entry in 2025.
Founders & leadership
DM
DD
Dr. David FisherCo-founder
DX
Dr. Xu WuCo-founder
DP
Duojia PanCo-founder
Investors · 1
Frequently asked questions
- What does Tascatx do?
- Tasca Therapeutics develops novel cancer therapies using mass spectrometry-based proteomics to identify cancer-causing proteins with auto-palmitoylation modifications, targeting previously unknown binding pockets for difficult-to-treat cancers. The company's lead program, CP-383, is in preclinical development with expected clinical trial entry in 2025.
- Who founded Tascatx?
- Tascatx was founded by Dr. Milenko Cicmil, Dr. David Fisher, Dr. Xu Wu, Duojia Pan.
- Who are Tascatx's investors?
- Tascatx's investors include Cure Ventures.
- Where is Tascatx headquartered?
- Tascatx is headquartered in Boston, US.